Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation

Haematologica

Volumn 97, Issue 1, 2012, Pages 116-122

  Berger, Martin David ^a   Gerber, Bernhard ^a   Arn, Kornelius ^a   Senn, Oliver ^b   Schanz, Urs ^a   Stussi, Georg ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

Acute leukemia; Hematopoietic stem cell transplantation; Red blood cells; Single unit; Transfusion

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN;

ADULT; ANEMIA; APLASIA; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE POLICY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTPATIENT; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SWITZERLAND; THROMBOCYTE TRANSFUSION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD TRANSFUSION, AUTOLOGOUS; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84855234790     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.047035     Document Type: Article

References (36)

1. Graham-Stewart C, Lond MB. A clinical survey of blood-transfusion. Lancet. 1960; 2(7147):421-4.
2. Alsever JB. The blood bank and homologous serum jaundice: a review of medicolegal considerations. N Engl J Med. 1959;261: 383-6.
3. Morton JH. Surgical transfusion practices, 1967. Surgery. 1969;65(3):407-16.
4. Crispen JF. The single-unit transfusion. A continuing problem. Pa Med. 1966;69(1): 44-8.
5. Reece RL, Beckett RS. Epidemiology of single-unit transfusion. A one-year experience in a community hospital. JAMA. 1966;195 (10):801-16.
6. Fadell EJ. Utilization of blood: a single-unit blood transfusion study. J Ky Med Assoc. 1967;65(6):573-5.
7. Domen RE. The single-unit transfusion. J Fla Med Assoc. 1986;73(11):855-7.
8. Ma M, Eckert K, Ralley F, Chin-Yee I. A retrospective study evaluating single-unit red blood cell transfusions in reducing allogene-ic blood exposure. Transfus Med (Oxford, England). 2005;15(4):307-12.
9. Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009;37(12):3124-57.
10. Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives. Transfus Med Hemother. 2009;36(6):351-482.
11. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet. 2007;370(9585):415-26.
12. Consensus conference. Perioperative red blood cell transfusion. JAMA. 1988;260(18): 2700-3.
13. Haematology BCFSI, Milligan DW, Grimwade D, Cullis JO, Bond L, Swirsky D, et al. Guidelines on the management of acute myeloid leukaemia in adults. Br J Haematol. 2006;135(4):450-74.
14. Force SOTSBCGT, Ferraris VA, Ferraris S P, Saha S P, Hessel EA, Haan CK, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007; 83(5 Suppl):S27-86.
15. Feagan BG, Wong CJ, Lau CY, Wheeler SL, Sue-A-Quan G, Kirkley A. Transfusion practice in elective orthopaedic surgery. Transfus Med (Oxford, England). 2001;11 (2):87-95.
16. Hébert PC, Wells G, Martin C, Tweeddale M, Marshall J, Blajchman M, et al. A Canadian survey of transfusion practices in critically ill patients. Transfusion Requirements in Critical Care Investigators and the Canadian Critical Care Trials Group. Crit Care Med. 1998;26(3):482-7.
17. Chohan SS, Mcardle F, McClelland DBL, Mackenzie SJ, Walsh TS. Red cell transfusion practice following the transfusion requirements in critical care (TRICC) study: prospective observational cohort study in a large UK intensive care unit. Vox Sang. 2003;84(3):211-8.
18. Boralessa H, Goldhill DR, Tucker K, Mortimer AJ, Grant-Casey J. National comparative audit of blood use in elective primary unilateral total hip replacement surgery in the UK. Ann R Coll Surg Engl. 2009;91(7):599-605.
19. Adès L, Chevret S, Raffoux E, de Botton S, Guerci A, Pigneux A, et al. Is cytarabine useful in the treatment of acute promyelo-cytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. J Clin Oncol. 2006;24(36):5703-10.
20. Löwenberg B, van Putten W, Theobald M, Gmür J, Verdonck L, Sonneveld P, et al. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med. 2003;349(8):743-52.
21. Gmür J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet. 1991;338 (8777):1223-6.
22. Kirkwood BR, Sterne JAC. Essential medical statistics. Blackwell Science Ltd. 2003 (2nd):501.
23. Special Communication. Joint Blood Council Transfusion Review Programm. JAMA. 1962:1-2.
24. Micolonghi T, Simon S, Paull A, Healey PJ. The single-unit transfusion in a community hospital-a critical evaluation. Improved blood transfusion practices may result in increased incidence of single-unit transfusions. R I Med J. 1966;49(9):533-6.
25. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion. 2010;50(4):753-65.
26. Carson JL, Hill S, Carless P, Hébert P, Henry D. Transfusion triggers: a systematic review of the literature. Transfus Med Rev. 2002;16(3):187-99.
27. Hill SR, Carless PA, Henry DA, Carson JL, Hebert PC, McClelland DB, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2002(2):CD002042.
28. Hajjar LA, Vincent J-L, Galas FRBG, Nakamura RE, Silva CMP, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA: the journal of the American Medical Association. 2010;304(14):1559-67.
29. Hébert PC, Fergusson DA. Red blood cell transfusions in critically ill patients. JAMA. 2002;288(12):1525-6.
30. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6): 409-17.
31. Carson JL, Terrin ML, Magaziner J, Chaitman BR, Apple FS, Heck DA, et al. Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS). Transfusion. 2006;46(12):2192-206.
32. Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion. 1999;39(10):1070-7.
33. Bush RL, Pevec WC, Holcroft JW. A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. Am J Surg. 1997;174(2):143-8.
34. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453-74.
35. Jansen AJG, Caljouw MAA, Hop WCJ, van Rhenen DJ, Schipperus MR. Feasibility of a restrictive red-cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemia. Transfus Med (Oxford, England). 2004;14(1):33-8.
36. Favre G, Fopp M, Gmür J, Tichelli A, Fey M F, Tobler A, et al. Factors associated with transfusion requirements during treatment for acute myelogenous leukemia. Ann Hematol. 1993;67(4):153-60.